"This grant is meaningful to me because it allows me to continue my research which is focused on novel immunotherapies for rare pediatric cancers," shares CRI-Bristol Myers Squibb Fellow Dr. Lauren Banks of @MSKCancerCenter. Learn more: https://t.co/FLZwlU1Gat #CancerResearch
On 4/26, we're launching a global educational series on molecular oncology, co-directed by MSK's Dr. Mrinal Gounder and @SewantiLimaye of @RFhospital Mumbai, to examine cancer signaling pathways and discuss nuances of precision therapies. Register today! https://t.co/AhceNM1nuN
Dr. Kelly shows that pembrolizumab + epacadostat is ineffective in #sarcoma but correlative studies noted lack of IDO inhibition. Provides some important insight into potential mechanism of drug failure, leaving many unanswered questions. @MSKSarcoma@MSK_DeptOfMed
We are thrilled to welcome Dr. Bob Maki back to the MSK family. Dr. Maki brings long-standing expertise in #sarcoma through innovative research and trials. A dedicated colleague, mentor, friend and a compassionate clinician. Clinics in Manhattan and Nassau campus. Welcome Bob!
As a recipient of numerous ASCO Conquer Cancer grants, I can attest to the power and value of these opportunities. https://t.co/HjA8Lk3ZIR. @MSKSarcoma@MSK_DeptOfMed@ASCO@ConquerCancerFd
Congratulations to all desmoid pts/families, pt advocacy @DTRFoundation, Mrinal Gounder @MSKCancerCenter desmoid team, co-investigators globally, @SpringWorksTx. A great model for drug development in @RareDiseases - pt advocacy working together w academia, industry & regulators.
Mrs. @MichelleObama has received nearly 2,000 letters every month — which are part of the inspiration behind her new book “The Light We Carry.”
Take a look at the story of one woman who wrote a letter in 2020 and found comfort in Mrs. Obama’s words during a difficult time.
MSK fellow extraordinaire, Dr. Lauren Banks provides insightful perspective into the status of immunotherapy for sarcoma. Privileged to co-mentor with Dr. Klebanoff with whom she's conducting ground breaking research @KlebanoffLab@WTapMD@MSK_DeptOfMed
Rare, often misdiagnosed, accounts for 1% of all adult cancers and 15 to 20% of childhood cancers. In 2022, an estimated 17,000 people will be diagnosed, and over 7,200 people will die, 42% of diagnosed cases.
Read more here: https://t.co/J0CNeiLgTo
#sarcomaawarenessmonth
Excited to announce @DrVickersUAB of @uabnews has been selected to serve as MSK President and CEO beginning this September. He is an internationally recognized pancreatic cancer surgeon and researcher and an academic medical leader. https://t.co/oW0p91ymQG
Nivolumab with bempegaldesleukin in sarcoma now published in @NatureComms. A collaborative effort with my colleagues @MSKSarcoma, @WTapMD, MSK computational biologists (Allison Richards, Mark Donoghue) and MDA colleagues @APConley77) https://t.co/YmdAxhQVdD @MSKCancerCenter 1/8
We're looking for a new postdoc to help with our NIH project on #desmoid tumors. Email or DM if you know someone who might be interested! https://t.co/rCUqHbBdO2